<DOC>
	<DOCNO>NCT00231114</DOCNO>
	<brief_summary>The objective randomized , double blind , sham-controlled study demonstrate safety effectiveness Alair System population subject severe asthma still symptomatic despite managed conventional therapy high dos inhale corticosteroid long-acting β2-agonists . The primary efficacy endpoint difference Study group change Asthma Quality Life Questionnaire ( AQLQ ) score Baseline average score 6- , 9- , 12-month follow-up visit . All outcome measure assess 12 month post-treatment . This multicenter , randomize , double-blind , sham-controlled study compare effect treatment Alair System conventional therapy inhale corticosteroid ( ICS ) long-acting β2-agonists ( LABA ) . A Bayesian adaptive approach sample size selection use randomization scheme 2:1 ( two Alair Group Subjects every one Control Group Subject ) .</brief_summary>
	<brief_title>Asthma Intervention Research 2 ( AIR2 ) Trial</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Subject adult age 18 65 year . Subject asthma take regular maintenance medication include Inhaled corticosteroid ( ICS ) AND long act ß2agonist ( LABA ) . Subject Prebronchodilator Forced Expiratory Volume one second ( FEV1 ) great equal 60 % predicted medication stabilization Baseline Period . Subject PC20 &lt; 8 mg/ml per methacholine inhalation test use standardize method . PC20 provocative concentration Provocholine® ( brand methacholine chloride ) result drop FEV1 20 % Baseline . Subject least two day asthma symptom 4weeks Baseline Diary Period . Subject nonsmoker 1 year great ( former smoker , less 10 pack year total smoking history ) . Subject Postbronchodilator FEV1 le 65 % . Subject 3 hospitalization exacerbation asthma previous year ; OR history lifethreatening asthma , define past intubation asthma , ICU admission asthma within prior 24 month . Subject history recurrent low respiratory tract infection require antibiotic ( 3 past 12 month ) . Subject history recurrent oral steroid use asthma ( 4 pulse oral steroid past 12 month ) . Subject know sensitivity medication require perform bronchoscopy ( lidocaine , atropine benzodiazepine ) . Subject know systemic hypersensitivity contraindication Methacholine chloride parasympathomimetic agent . Subject medical criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Asthma</keyword>
</DOC>